Viking Launches Two Phase 3 Trials for Oral Obesity Drug
Viking Therapeutics launched two late-stage trials of its experimental oral weight-loss treatment VK2735.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.